Normal TSH · Low Free T4 · Second Trimester
Labcorp Birmingham · Specimen: 06/05/2026 · Ordering Physician: Dr. Brown
Normal serum TSH with a Free T4 below the reference range — in the absence of prior thyroid disease.
Occurs in the 2nd and 3rd trimesters. Prevalence is estimated at 2–4% of pregnancies.
This is not overt or subclinical hypothyroidism. TSH remains normal — the pituitary axis is intact.
Standard direct immunoassays are not validated for pregnancy. High TBG and lower albumin cause systematic underestimation in the 2nd–3rd trimesters. ATA 2017
hCG-driven TSH suppression resolves by 2nd trimester. TSH normalizes while Free T4 physiologically declines. SMFM
| Parameter | Isolated Hypothyroxinemia (This Patient) |
Subclinical / Overt Hypothyroidism |
|---|---|---|
| TSH Level | Normal (0.2–3.0 mIU/L) | Elevated (>2.5–4.0 mIU/L) |
| Free T4 | Low (assay artifact or iodine deficiency) | Normal (subclinical) or Low (overt) |
| Primary Mechanism | TBG elevation / immunoassay interference | Primary thyroid gland failure |
| Clinical Action | Reassurance · Iodine · Monitor TSH | Levothyroxine replacement |
| Levothyroxine? | NOT indicated | Indicated — titrate to TSH target |
ATA guidelines strongly advise against thyroid hormone supplementation for isolated maternal hypothyroxinemia. ATA 2017
Multiple large randomized controlled trials demonstrate no improvement in obstetric outcomes or child neurocognitive development with levothyroxine treatment.
Unnecessary treatment introduces clinical burden and potential maternal/fetal risk — with no demonstrable benefit.
The pituitary-thyroid axis is intact. This is not hypothyroidism.
Low Free T4 is a known limitation of direct immunoassays in the 2nd–3rd trimesters.
Treatment is not indicated and not supported by RCT evidence. ATA
Repeat TSH in 4–6 weeks. Confirm iodine adequacy. Reassure patient.
Reference: American Thyroid Association Guidelines for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum (2017) · DoctorsWhoCode.blog